HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...
BioNTech Completes Acquisition of Biotheus
Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...
The Evolution Of Product Management: Integrating Generative AI With Agile Principles
The lessons of Agile’s missteps provide a road map for AI’s future, emphasizing the importance of strategy, judgment and the ...